News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 28, 2013, 09:40 ET

Oramed CEO to Present at New York Biotechnology Association and The Israel Conference's Fast & Cool™ Session

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the...

May 17, 2013, 07:50 ET

Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the United...

May 01, 2013, 07:15 ET

Clinical Results for Oramed's Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems of drugs currently administered by...

Apr 29, 2013, 07:40 ET

Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems of drugs currently administered by...

Apr 22, 2013, 09:15 ET

Oramed CEO to be Panelist at BIO International Convention Breakout Session on Israel Becoming Biotech Leader

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that the Company's CEO...

Apr 18, 2013, 03:21 ET

Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that its abstract,...

Apr 16, 2013, 09:15 ET

Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced a key addition to...

Apr 11, 2013, 03:11 ET

Oramed Submits New IND Application for Oral Insulin Trial in the US

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

Apr 03, 2013, 07:45 ET

Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

Mar 21, 2013, 09:15 ET

Oramed Pharmaceuticals Selected to Present at the 73rd Scientific Sessions of the American Diabetes Association in Chicago, IL, June 21-25, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its...

Feb 18, 2013, 09:15 ET

Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that Dr. Ehud Arbit,...

Feb 14, 2013, 09:27 ET

Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in...

Feb 11, 2013, 09:45 ET

Oramed Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that their February...

Feb 07, 2013, 08:30 ET

Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market

Oramed Pharmaceuticals Inc. (OTCQB: ORMPD), a developer of oral drug delivery systems, announced today that NASDAQ has approved the company's...

Feb 05, 2013, 07:00 ET

Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th

Oramed Pharmaceuticals Inc. (OTC:ORMPD) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that Nadav Kidron,...

Jan 22, 2013, 16:30 ET

Oramed Pharmaceuticals Announces Reverse Stock Split

Oramed Pharmaceuticals Inc. (OTCQB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its previously...

Jan 07, 2013, 09:20 ET

Oramed Pharmaceuticals Files Investigational New Drug Application with the FDA for Oral Insulin

Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has filed...

Dec 11, 2012, 09:20 ET

Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has completed...

Nov 07, 2012, 09:20 ET

Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012

Oramed Pharmaceuticals Inc. (OTCBB: ORMP; www.oramed.com), a developer of oral delivery systems, announced today that results of a study performed...

Oct 18, 2012, 09:20 ET

Former Johnson & Johnson and Bausch & Lomb Executive, Gerald Ostrov, Joins Oramed Pharmaceuticals' Board of Directors

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that Gerald Ostrov,...